Effect of L-carnitine and/or L-acetyl-carnitine in nutrition treatment for male infertility: a systematic review
X Zhou, F Liu, S Zhai - 2007 - srhr.dspace-express.com
The aim of this systematic review was to quantify the efficacy of L-carnitine (LC) and/or L-acetyl-carnitine
(LAC) in nutrition treatment for male infertility according to present clinical …
(LAC) in nutrition treatment for male infertility according to present clinical …
Trough concentration of voriconazole and its relationship with efficacy and safety: a systematic review and meta-analysis
Objectives The optimum trough concentration of voriconazole for clinical response and
safety is controversial. The objective of this review was to determine the optimum trough …
safety is controversial. The objective of this review was to determine the optimum trough …
[HTML][HTML] SGLT2 inhibitors and risk of cancer in type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
Aims/hypothesis The association between sodium–glucose cotransporter 2 (SGLT2) inhibitors
and the risk of cancer in individuals with type 2 diabetes remains uncertain. This study …
and the risk of cancer in individuals with type 2 diabetes remains uncertain. This study …
Evidence-based guideline for therapeutic drug monitoring of vancomycin: 2020 update by the division of therapeutic drug monitoring, Chinese pharmacological …
…, Z Zhao, W Zhou, XT Zeng, S Zhai - Clinical Infectious …, 2020 - academic.oup.com
Background Clinical practice guidelines or recommendations often require timely and regular
updating as new evidence emerges, because this can alter the risk-benefit trade-off. The …
updating as new evidence emerges, because this can alter the risk-benefit trade-off. The …
Pioglitazone and bladder cancer risk: a systematic review and meta‐analysis
Current evidence about the association between pioglitazone and bladder cancer risk
remains conflict. We aimed to assess the risk of bladder cancer associated with the use of …
remains conflict. We aimed to assess the risk of bladder cancer associated with the use of …
[HTML][HTML] Elevated serum magnesium associated with SGLT2 inhibitor use in type 2 diabetes patients: a meta-analysis of randomised controlled trials
H Tang, X Zhang, J Zhang, Y Li, LC Del Gobbo, S Zhai… - Diabetologia, 2016 - Springer
Aims/hypothesis By analysing available evidence from randomised controlled trials (RCTs),
we aimed to examine whether and to what extent sodium–glucose cotransporter 2 (SGLT2) …
we aimed to examine whether and to what extent sodium–glucose cotransporter 2 (SGLT2) …
Efficacy and safety of antiviral treatment for COVID-19 from evidence in studies of SARS-CoV-2 and other acute viral infections: a systematic review and meta-analysis
BACKGROUND: Antiviral medications are being given empirically to some patients with
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …
coronavirus disease 2019 (COVID-19). To support the development of a COVID-19 …
[HTML][HTML] Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline
…, D Liu, F Liu, J Phua, A Shen, T Huo, B Du, S Zhai… - Cmaj, 2020 - Can Med Assoc
2019 (COVID-19) is either indirect (from studies of influenza, severe acute respiratory
syndrome and Middle East respiratory syndrome) or from several observational studies and …
syndrome and Middle East respiratory syndrome) or from several observational studies and …
Sodium‐glucose co‐transporter‐2 inhibitors and risk of adverse renal outcomes among patients with type 2 diabetes: a network and cumulative meta‐analysis of …
…, D Li, J Zhang, Y Li, T Wang, S Zhai… - Diabetes, Obesity and …, 2017 - Wiley Online Library
Aim To compare the associations of individual sodium‐glucose co‐transporter‐2 ( SGLT2 )
inhibitors with adverse renal outcomes in patients with type 2 diabetes mellitus ( T2DM ). …
inhibitors with adverse renal outcomes in patients with type 2 diabetes mellitus ( T2DM ). …
[HTML][HTML] Individualized medication of voriconazole: a practice guideline of the division of therapeutic drug monitoring, Chinese Pharmacological Society
…, X Zhang, X Ke, G Du, K Yang, S Zhai - Therapeutic drug …, 2018 - journals.lww.com
Background: Voriconazole (VRZ) is a second-generation triazole antifungal agent with
broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily …
broad-spectrum activity. It is available in both intravenous and oral formulations, and is primarily …
